Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion

OBJECTIVE: This multicenter, randomized, controlled, open‐label trial examined weight‐related quality of life, control over eating behaviour and sexual function after 26 weeks of treatment with either 32 mg naltrexone sustained release (SR)/360 mg bupropion SR plus a comprehensive lifestyle interven...

Descripción completa

Detalles Bibliográficos
Autores principales: Halseth, A., Shan, K., Gilder, K., Malone, M., Acevedo, L., Fujioka, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893468/
https://www.ncbi.nlm.nih.gov/pubmed/29670752
http://dx.doi.org/10.1002/osp4.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893468/
https://www.ncbi.nlm.nih.gov/pubmed/29670752
http://dx.doi.org/10.1002/osp4.156

Ejemplares similares